Affinity DataKi: 67nMAssay Description:Ability to inhibit purine nucleoside phosphorylase (PNP)More data for this Ligand-Target Pair
Affinity DataKi: 176nMAssay Description:Ability to inhibit purine nucleoside phosphorylase (PNP)More data for this Ligand-Target Pair
Affinity DataKi: 200nMAssay Description:Ability to inhibit purine nucleoside phosphorylase (PNP)More data for this Ligand-Target Pair
Affinity DataKi: 830nMAssay Description:Ability to inhibit purine nucleoside phosphorylase (PNP)More data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Ability to inhibit purine nucleoside phosphorylase (PNP)More data for this Ligand-Target Pair
Affinity DataKi: 2.90E+3nMAssay Description:Ability to inhibit purine nucleoside phosphorylase (PNP)More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.0300nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Gsk Pharmaceuticals R&D
Curated by ChEMBL
Gsk Pharmaceuticals R&D
Curated by ChEMBL
Affinity DataIC50: >0.158nMAssay Description:Inhibition of recombinant His6-Tev-LRRK2 (1326 to 2527 residues) (unknown origin) using LRRKtide as substrate preincubated for 30 mins followed by su...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.158nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Agonist activity at CCR10 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Agonist activity at CXCR3 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Agonist activity at CCR9 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at CXCR5 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Agonist activity at CXCR7 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.631nMAssay Description:Agonist activity at CCR8 (unknown origin)More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at human recombinant Gal4-VP16 fused-CXCR2 assessed as inhibition of CXCL1-mediated lactamase reporter gene expression after over...More data for this Ligand-Target Pair
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Gsk Pharmaceuticals R & D
Curated by ChEMBL
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair
TargetBifunctional epoxide hydrolase 2(Homo sapiens (Human))
Shenyang Pharmaceutical University
Curated by ChEMBL
Shenyang Pharmaceutical University
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of sEH (unknown origin)More data for this Ligand-Target Pair